Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$39.13 - $47.24 $4.24 Million - $5.12 Million
-108,400 Reduced 20.57%
418,608 $17 Million
Q2 2023

Aug 11, 2023

SELL
$43.93 - $46.76 $3.49 Million - $3.71 Million
-79,448 Reduced 13.1%
527,008 $23.7 Million
Q1 2023

May 12, 2023

BUY
$45.29 - $50.76 $9.41 Million - $10.5 Million
207,748 Added 52.11%
606,456 $27.9 Million
Q4 2022

Feb 13, 2023

SELL
$41.91 - $50.48 $8.47 Million - $10.2 Million
-202,000 Reduced 33.63%
398,708 $19.9 Million
Q3 2022

Nov 14, 2022

BUY
$40.9 - $50.42 $6.43 Million - $7.92 Million
157,100 Added 35.41%
600,708 $24.8 Million
Q2 2022

Aug 12, 2022

BUY
$42.98 - $49.77 $7.66 Million - $8.87 Million
178,300 Added 67.2%
443,608 $20.9 Million
Q1 2022

May 13, 2022

BUY
$42.23 - $54.3 $11.2 Million - $14.4 Million
265,308 New
265,308 $13 Million
Q4 2021

Feb 11, 2022

SELL
$50.62 - $56.47 $5.61 Million - $6.26 Million
-110,908 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$46.55 - $56.83 $5.16 Million - $6.3 Million
110,908 New
110,908 $5.73 Million
Q4 2020

Feb 10, 2021

SELL
$46.09 - $54.74 $10.4 Million - $12.4 Million
-226,682 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$42.51 - $52.42 $2.08 Million - $2.56 Million
-48,813 Reduced 17.72%
226,682 $11.8 Million
Q2 2020

Aug 13, 2020

BUY
$39.49 - $44.36 $10.9 Million - $12.2 Million
275,495 New
275,495 $11.8 Million
Q3 2019

Nov 13, 2019

SELL
$32.73 - $40.81 $353,745 - $441,074
-10,808 Closed
0 $0
Q2 2019

Aug 12, 2019

SELL
$35.73 - $41.39 $5.62 Million - $6.51 Million
-157,200 Reduced 93.57%
10,808 $438,000
Q1 2019

May 14, 2019

SELL
$33.78 - $40.68 $7.54 Million - $9.08 Million
-223,100 Reduced 57.04%
168,008 $6.84 Million
Q4 2018

Feb 13, 2019

BUY
$32.65 - $37.95 $12.8 Million - $14.8 Million
391,108 New
391,108 $13.5 Million

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $9.16B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.